{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T22:01:01Z","timestamp":1784325661398,"version":"3.55.0"},"reference-count":32,"publisher":"Wiley","issue":"32","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402350"],"award-info":[{"award-number":["82402350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Small"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Neuroinflammation plays an irreplaceable part in the pathogenesis and progression of Parkinson's disease (PD). While anti\u2010inflammatory nanomedicine offers new hope for PD treatment, the nano\u2010biological effects that govern their therapeutic outcomes remain largely unexplored. Herein, after investigating the mechanism of action of lentinan (LNT) on PD by network pharmacology, we report LNT and Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    integrated nanosystems (Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT) as anti\u2010neuroinflammatory agents for PD treatment. Proteomics analyses found that there are significant differences in protein corona composition between Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    and Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT, and the protein coronas in Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT are beneficial for BBB traversing and brian accumulation. In vivo and in vitro studies have shown that Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT effectively alleviates the behavioral and pathological symptoms of PD by eliminating reactive oxygen species and reducing neuroinflammation. Transcriptomics further revealed the vital part of the phenotypic transformation of microglia and inflammatory response in the action of Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT on the PD model. In summary, our study highlights the clinical application prospects of Mn\n                    <jats:sub>3<\/jats:sub>\n                    O\n                    <jats:sub>4<\/jats:sub>\n                    @LNT by benefiting the BBB traversing and promoting neuroinflammation mitigation in PD models.\n                  <\/jats:p>","DOI":"10.1002\/smll.202509328","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:06:17Z","timestamp":1776841577000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lentinan\u2010Enhanced Mn\n                    <sub>3<\/sub>\n                    O\n                    <sub>4<\/sub>\n                    Nanoparticles for Neuroinflammation Relief and Parkinson's Disease Treatment"],"prefix":"10.1002","volume":"22","author":[{"given":"Ruixue","family":"Wei","sequence":"first","affiliation":[{"name":"Department of Cerebrovascular Diseases The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"},{"name":"Zhengzhou Key Laboratory of Bio\u2010Nanomedicine for Neurodegenerative Diseases  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangkuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"},{"name":"Zhengzhou Key Laboratory of Bio\u2010Nanomedicine for Neurodegenerative Diseases  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurology The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"},{"name":"Zhengzhou Key Laboratory of Bio\u2010Nanomedicine for Neurodegenerative Diseases  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyang","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Life Sciences Zhengzhou University  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Nephrology The First Affiliated Hospital of Zhengzhou University Zhengzhou University  Zhengzhou P. R. China"},{"name":"Research Institute of Nephrology Zhengzhou University the First Affiliated Hospital of Zhengzhou University  Zhengzhou P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0094-1187","authenticated-orcid":false,"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Diseases The Second Affiliated Hospital of Zhengzhou University  Zhengzhou China"},{"name":"Zhengzhou Key Laboratory of Bio\u2010Nanomedicine for Neurodegenerative Diseases  Zhengzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104930"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.2742"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2005.08.002"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115302"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01566-y"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2007.08.007"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54515-4"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410070"},{"key":"e_1_2_8_10_1","first-page":"11","article-title":"Constitutive Expression of CX3CR1\u2010BAC\u2010Cre Introduces Minimal off\u2010target Effects in Microglia","volume":"3","author":"Mroue\u2010Ruiz F. H.","year":"2024","journal-title":"BioRxiv"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00545-9"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-26"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.02.043"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15121458"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-101803"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3390\/nutraceuticals4020011"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.165968"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2019.02.013"},{"issue":"1","key":"e_1_2_8_19_1","first-page":"90","article-title":"Effects of Lentinan of Peripheral Blood Mononuclear Cell Expression of Interleukin\u20102 Receptor in Patients with Chronic hepatitis B in Vivo and in Vitro","volume":"23","author":"Wan K.","year":"1998","journal-title":"Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University"},{"issue":"5","key":"e_1_2_8_20_1","first-page":"193","article-title":"A Phase II Controlled Study of a Combination of the Immune Modulator, Lentinan, with Didanosine (ddI) in HIV Patients with CD4 Cells of 200\u2013500\/mm3","volume":"26","author":"Gordon M.","year":"1995","journal-title":"Journal of Medicine"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c07205"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101316"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7SC05476A"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201708573"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.0c09029"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120786"},{"issue":"1","key":"e_1_2_8_27_1","first-page":"105","article-title":"Anti\u2010Parkinsonian Therapy: Strategies for Crossing the Blood\u2010Brain Barrier and Nano\u2010Biological Effects of Nanomaterials","volume":"14","author":"Cheng G.","year":"2022","journal-title":"Nanomicro Lett"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-021-00272-1"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202214826"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111541"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805135105"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba3967"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002797"}],"container-title":["Small"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/smll.202509328","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/smll.202509328","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/smll.202509328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:52:57Z","timestamp":1781520777000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/smll.202509328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":32,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/smll.202509328"],"URL":"https:\/\/doi.org\/10.1002\/smll.202509328","archive":["Portico"],"relation":{},"ISSN":["1613-6810","1613-6829"],"issn-type":[{"value":"1613-6810","type":"print"},{"value":"1613-6829","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"2025-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e09328"}}